Implantate AG, a global medical device company focused on trauma products and biomaterials for the orthopedic market, has extended the existing contracts of their three executive board members for another three years until the end of the financial year 2015. "We are glad to have accomplished the extension of the executive management contracts. With this successful team, we are able to further implement our focus strategy and concentrate on value creation as well as sustainable and profitable growth," said Rubino di Girolamo, chairman of the supervisory board.
More Articles on Orthopedic Devices:
Spinal Elements to Donate Allograft Proceeds to Charity
Medtronic Launches Complementary Instrument Set for BRYAN Cervical Disc
SkelRegen Forms With Focus on Musculoskeletal Care